598 related articles for article (PubMed ID: 17584993)
21. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.
Stevenson DD; Simon RA
J Allergy Clin Immunol; 2001 Jul; 108(1):47-51. PubMed ID: 11447381
[TBL] [Abstract][Full Text] [Related]
22. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
[TBL] [Abstract][Full Text] [Related]
23. [Asthma with hypersensitivity to aspirin].
Nizankowska-Mogilnicka E
Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272
[TBL] [Abstract][Full Text] [Related]
24. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
[TBL] [Abstract][Full Text] [Related]
25. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
26. [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
Ahlbach S; Usadel KH; Kaufmann R; Boehncke WH
Med Klin (Munich); 2003 Apr; 98(5):242-4. PubMed ID: 12721666
[TBL] [Abstract][Full Text] [Related]
27. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
28. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
[TBL] [Abstract][Full Text] [Related]
29. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years.
Setkowicz M; Mastalerz L; Podolec-Rubis M; Sanak M; Szczeklik A
J Allergy Clin Immunol; 2009 Jan; 123(1):174-8. PubMed ID: 18842291
[TBL] [Abstract][Full Text] [Related]
30. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics.
Pierzchalska M; Soja J; Woś M; Szabó Z; Nizankowska-Mogielnicka E; Sanak M; Szczeklik A
J Physiol Pharmacol; 2007 Jun; 58(2):207-18. PubMed ID: 17622692
[TBL] [Abstract][Full Text] [Related]
32. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
33. Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics.
Jedrzejczak-Czechowicz M; Lewandowska-Polak A; Bienkiewicz B; Kowalski ML
Clin Exp Allergy; 2008 Jul; 38(7):1108-16. PubMed ID: 18462455
[TBL] [Abstract][Full Text] [Related]
34. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
[TBL] [Abstract][Full Text] [Related]
36. Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients.
Morgan T; Bajrovic N; Silar M; Kosnik M; Korosec P
Int Arch Allergy Immunol; 2009; 149(4):378-84. PubMed ID: 19295242
[TBL] [Abstract][Full Text] [Related]
37. The broken balance in aspirin hypersensitivity.
Szczeklik A; Sanak M
Eur J Pharmacol; 2006 Mar; 533(1-3):145-55. PubMed ID: 16457808
[TBL] [Abstract][Full Text] [Related]
38. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
de Weck A; Sanz ML; Gamboa P
Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma.
Kim SH; Park HS
Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):17-22. PubMed ID: 16505607
[TBL] [Abstract][Full Text] [Related]
40. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
Williams AN; Simon RA; Woessner KM; Stevenson DD
J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
